Cargando…

Assessment of Dermal Absorption of Aluminum from a Representative Antiperspirant Formulation Using a (26)Al Microtracer Approach

A clinical pharmacokinetic study was performed in 12 healthy women to evaluate systemic exposure to aluminum following topical application of a representative antiperspirant formulation under real‐life use conditions. A simple roll‐on formulation containing an extremely rare isotope of aluminum ((26...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Ligt, Rianne, van Duijn, Esther, Grossouw, Dimitri, Bosgra, Sieto, Burggraaf, Jacobus, Windhorst, Albert, Peeters, Pierre A.M., van der Luijt, Gerrit A., Alexander‐White, Camilla, Vaes, Wouter H.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226111/ https://www.ncbi.nlm.nih.gov/pubmed/30052317 http://dx.doi.org/10.1111/cts.12579

Ejemplares similares

Assessment of dermal absorption of aluminium from a representative antiperspirant formulation using a ((26)Al)Al microtracer approach: a follow-up study in humans
por: de Ligt, Rianne, et al.
Publicado: (2022)

The Effects of Antiperspirant Aluminum Chlorohydrate on the Development of Antibiotic Resistance in Staphylococcus epidermidis
por: Aras, Ayse, et al.
Publicado: (2023)

The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study
por: van Groen, Bianca D., et al.
Publicado: (2020)

Proof of Concept: First Pediatric [(14)C]microtracer Study to Create Metabolite Profiles of Midazolam
por: van Groen, Bianca D., et al.
Publicado: (2020)

Copper chloride antiperspirant action
por: Bloom, Ernest, et al.
Publicado: (2012)

Underarm antiperspirants/deodorants and breast cancer
por: Darbre, Philippa D
Publicado: (2009)

The effect of habitual and experimental antiperspirant and deodorant product use on the armpit microbiome
por: Urban, Julie, et al.
Publicado: (2016)

Opportunities in low-level radiocarbon microtracing: applications and new technology
por: Vuong, Le Thuy, et al.
Publicado: (2015)

Antiperspirant effects and mechanism investigation of Mulisan decoction in rats based on plasma metabolomics
por: Ma, Shan-Peng, et al.
Publicado: (2022)

Nonclinical Exon Skipping Studies with 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn−/− Mice Inspired by Clinical Trial Results
por: van Putten, Maaike, et al.
Publicado: (2019)

Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination
por: Mahar, Kelly M., et al.
Publicado: (2021)

Structure–Function Correlations in the Mechanism of Action of Key Antiperspirant Agents Containing Al(III) and ZAG Salts
por: Dawn, Arnab, et al.
Publicado: (2022)

Long-Term Use of Antiperspirant is Associated with a Low Risk of Postoperative Complications in Patients with Axillary Osmidrosis
por: Ho, Wen-Tsao, et al.
Publicado: (2022)

Pre-Column Derivatization HPLC Procedure for the Quantitation of Aluminium Chlorohydrate in Antiperspirant Creams Using Quercetin as Chromogenic Reagent
por: Kalogria, Eleni, et al.
Publicado: (2014)

Deodorant/antiperspirant use and hair removal practices for hidradenitis suppurativa: recommendations from a single-center survey
por: Cutler, Brett, et al.
Publicado: (2023)

Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach
por: Flach, Stephen, et al.
Publicado: (2016)

Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients
por: van Andel, L., et al.
Publicado: (2017)

Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin
por: Raje, Sangeeta, et al.
Publicado: (2018)

Pediatric Microdose Study of [(14)C]Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept
por: Mooij, Miriam G., et al.
Publicado: (2014)

Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients
por: van Andel, L., et al.
Publicado: (2017)

An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans
por: Kim, Anhye, et al.
Publicado: (2020)

Investigation of the human metabolism and disposition of the prolyl hydrolase inhibitor daprodustat using IV microtracer with Entero‐Test bile string
por: Tai, Guoying, et al.
Publicado: (2023)

The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [(14)C]-BI 425809 in Healthy Males
por: Burkard, Ute, et al.
Publicado: (2021)

A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach
por: Wang, Xiaomin, et al.
Publicado: (2019)

The Oral Pheneticillin Absorption Test: An Accurate Method to Identify Patients with Inadequate Oral Pheneticillin Absorption
por: Dijkmans, Anneke C., et al.
Publicado: (2019)

Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [(14)C]‑BI 425809 in Healthy Males
por: Burkard, Ute, et al.
Publicado: (2022)

Pharmacokinetics, Excretion, and Mass Balance of [(14)C]‐Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men
por: Ambery, Claire, et al.
Publicado: (2018)

Guidance on dermal absorption
por: Buist, Harrie, et al.
Publicado: (2017)

Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide
por: Kourkouta, Eleni, et al.
Publicado: (2019)

Pharmacokinetics, Biotransformation, and Excretion of [(14)C]Etelcalcetide (AMG 416) Following a Single Microtracer Intravenous Dose in Patients with Chronic Kidney Disease on Hemodialysis
por: Subramanian, Raju, et al.
Publicado: (2016)

A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a (14)C‐Microtracer Approach
por: Singh, Ravi Shankar P., et al.
Publicado: (2022)

Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay
por: Colaianna, Marilena, et al.
Publicado: (2016)

Analysis of finite dose dermal absorption data: Implications for dermal exposure assessment
por: Frasch, H Frederick, et al.
Publicado: (2014)

P816: PHARMACODYNAMIC ACTIVITY OF GEN3014 (HEXABODY-CD38) IN PATIENTS WITH MULTIPLE MYELOMA SUPPORTS ENHANCED COMPLEMENT DEPENDENT CYTOTOXICITY OF GEN3014 COMPARED TO DARATUMUMAB
por: Hiemstra, Ida H., et al.
Publicado: (2023)

Successful Use of [(14)C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism
por: Mooij, Miriam G., et al.
Publicado: (2017)

A two-step deconvolution-analysis-informed population pharmacodynamic modeling approach for drugs targeting pulsatile endogenous compounds
por: van Esdonk, Michiel J., et al.
Publicado: (2017)

Model informed quantification of the feed‐forward stimulation of growth hormone by growth hormone‐releasing hormone
por: van Esdonk, Michiel J., et al.
Publicado: (2020)

Salicylate Toxicity from Ingestion and Continued Dermal Absorption
por: Chin, Rachel L., et al.
Publicado: (2007)

Dermal absorption of a dilute aqueous solution of malathion
por: Scharf, John E, et al.
Publicado: (2008)

Acknowledging Receipts? New Evidence for Dermal Absorption of Bisphenols
por: Schmidt, Silke
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k4hpj5ed2gpr05udd1dpo7v0t4